Marleen Kok

28PUBLICATIONS
202CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Deep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Mar 19, 2026
Immunity, Age, and Luminal Breast Cancer: Understanding the Holy Trinity.

Roberto Salgado, Marleen Kok

|Feb 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Noah F Greenwald, Iris Nederlof, Cameron Sowers

|Sep 04, 2025
Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Federica Miglietta, Manon De Graaf, Claudio Vernieri

|Jun 24, 2025
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

Gil Awada, Tina Cascone, Michiel S van der Heijden

|Jan 22, 2025
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality.

Noor A M Bakker, Hannah Garner, Ewald van Dyk

Pageof 5

Frequent Collaborators

13 joint publications

Hugo M Horlings

6 joint publications

Ton N Schumacher

6 joint publications

Iris Nederlof

6 joint publications

Roberto Salgado